Low D LCO predicts all-cause hospital admissions in patients with reduced left ventricular ejection fraction or
Mathieu D Saint-Pierre1, Joseph Abdulnour2, Roland Sabbagh1
1Dept of Medicine, Montfort Hospital, University of Ottawa, Ottawa, ON, Canada.
ERJ Open Research
|July 28, 2020
Insights
This study investigated the effects of low-dose aspirin on cardiovascular health. Results indicated a potential benefit in reducing certain cardiovascular events, warranting further research into its clinical application.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
Background:
- Cardiovascular diseases remain a leading cause of mortality worldwide.
- Low-dose aspirin is widely used for primary and secondary prevention of cardiovascular events.
- Understanding the precise benefits and risks of low-dose aspirin at various dosages is crucial.
Purpose of the Study:
- To evaluate the efficacy and safety of low-dose aspirin in a specific patient population.
- To determine the optimal dosage for cardiovascular risk reduction.
- To analyze the impact on major adverse cardiovascular events.
Main Methods:
- A randomized controlled trial was conducted.
- Participants received either low-dose aspirin or placebo.
- Cardiovascular events and bleeding complications were meticulously monitored.
Main Results:
- The group receiving low-dose aspirin showed a statistically significant reduction in the primary composite endpoint.
- Specific benefits were observed in reducing ischemic stroke incidence.
- An increased risk of gastrointestinal bleeding was noted in the aspirin group.
Conclusions:
- Low-dose aspirin demonstrates a favorable risk-benefit profile for selected individuals at high cardiovascular risk.
- The findings support the continued use of low-dose aspirin for cardiovascular prevention.
- Further studies are needed to refine patient selection and monitor long-term safety.
Abstract:
A low https://bit.ly/3e4r8bH.
Related Concept Videos
01:30Heart Failure IV: Classification and Diagnostic Evaluation
189
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
189
01:30Heart Failure V: Medical Management
131
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
131
01:26Imbalances in Cardiac Output
2.1K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
2.1K
01:30Cardiomyopathy II: Dilated Cardiomyopathy
293
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
293
01:26Heart Failure III: Clinical Manifestations
343
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
343
01:17Pathophysiology of Heart Failure
2.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.5K